Company intelligence / Profile preview

Ogier

Ownership: Private
Development stage: Other

Overview

Ogier is an international law firm specializing in offshore legal advice for corporate transactions including those involving biotech and pharmaceutical companies[1][5]. It does not develop drugs or medical technologies itself and should not be confused with any similarly named entities in the life sciences sector. The firm's work includes advising on IPOs and mergers for healthcare clients but it remains strictly a provider of legal services rather than a participant in drug development or commercialization[1][5].

Industry: Consulting

Beyond the preview

Go deeper on Ogier.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ogier.

Explore the full profile